Indian Drug Firms

Analysts expect double-digit growth for pharma major even if Q1 disappointed

Brand named Kerendia (finerenone) will cost Rs 97.5 per day as treatment cost in India

Finds links to Hawala sale of medicines to Afghanistan

In a Q&A, Rehan A Khan talks about his firm's strong focus on R&D and its commitment to making drugs affordable

The Union Ministry of Health has made amendments to the Drugs Rules, 1945, to implement this

The government is engaging with the drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, says Chemicals and Fertilizers Ministry

The company pleaded guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration (FDA) plant inspection, the Department of Justice said

To support its argument, Patanjali has released a bunch of scientific papers on its research for a Covid-19 medicine that was published in popular peer-reviewed journals

Have increased raw material buffer stock by at least 40 days in recent months

Indian firms with specialty product portfolios will do better than peers

Europe is the third-largest market for Indian drug makers after the US and Africa